香港股市 已收市

SK hynix Inc. (000660.KS)

KSE - KSE 延遲價格。貨幣為 KRW。
加入追蹤清單
177,800.00+7,200.00 (+4.22%)
收市:03:30PM KST

SK hynix Inc.

2091 Gyeongchung-daero
Bubal-eup
Icheon-si
South Korea
82 31 5185 4114
https://www.skhynix.com

版塊Technology
行業Semiconductors
全職員工

高階主管

名稱頭銜支付行使價出生年份
Dr. Noh-Jung KwakPresident, CEO & Executive Director1965
Dong Sub KimPresident and Head of Communication & External Affairs
Woo-Hyun KimVP & Head of Finance
Seong Hwan ParkHead of Investor Relations
Sang-Rak LeeVP & Head of Sales
Joon ChoiVP & Head of Marketing
Myoung-Soo ParkHead of DRAM Marketing
Jeong Tae KimHead of NAND Marketing
Seon Yong ChaVice President & Head of R&D
Jung Sik ParkVP and Head of Quality & Reliability Assurance
截止 為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 KRW。

描述

SK hynix Inc., together with its subsidiaries, engages in the manufacture, distribution, and sale of semiconductor products in Korea, China, rest of Asia, the United States, and Europe. It offers DRAM, NAND storage products, SSD, MCP, and CMOS image sensors, as well as Compute Express Link (CXL), which utilizes the peripheral component interconnect express interface that helps in increasing the efficiency of CPUs, GPUs, accelerators, and memory. The company provides its products for server, networking, mobile, personal computer, consumer, and automotive applications. it is also involved in construction, business support, industrial material supply, semiconductor apparel manufacturing and baking, hospital operation, building maintenance, education, information telecommunication, investment and investment advisory, and money market trust activities. The company was formerly known as Hynix Semiconductor Inc. and changed its name to SK hynix, Inc. in March 2012. SK hynix, Inc. was founded in 1949 and is headquartered in Icheon-si, South Korea.

公司管治

截至 2024年4月1日 止,SK hynix Inc. 的 ISS 管治質素評分為 1。 Pillar 分數正在審核中:1;董事會:1;股東權利:4;現金賠償:6。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。